Impact of epidermal growth factor receptor protein and gene alteration on Taiwanese hepatocellular carcinomas-Reference-Cited by-同舟云学术

Impact of epidermal growth factor receptor protein and gene alteration on Taiwanese hepatocellular carcinomas

Published:2015-07-27 Issue:9 Volume:30 Page:1397-1404
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Su Yu-Hung¹,Ng Kwai-Fong²,Yu Ming-Chin³,Wu Ting-Jung³,Yeh Ta-Sen³,Lee Wei-Chen³,Lin Yong-Shiang²,Hsieh Tsung-Han⁴,Lin Chun-Yen⁵,Yeh Chau-Ting⁶,Chen Tse-Ching¹²

Affiliation:

1. Cancer Diagnostic Laboratory; Lin-Kou Chang Gung Memorial Hospital; Tao-Yuan Taiwan

2. Department of Pathology; Lin-Kou Chang Gung Memorial Hospital, Chang Gung University School of Medicine; Tao-Yuan Taiwan

3. Department of General Surgery; Lin-Kou Chang Gung Memorial Hospital, Chang Gung University School of Medicine; Tao-Yuan Taiwan

4. Department of Biobank; Lin-Kou Chang Gung Memorial Hospital, Chang Gung University School of Medicine; Tao-Yuan Taiwan

5. Department of Hepato-Gastroenterology; Lin-Kou Chang Gung Memorial Hospital, Chang Gung University School of Medicine; Tao-Yuan Taiwan

6. Liver Research Center; Lin-Kou Chang Gung Memorial Hospital, Chang Gung University School of Medicine; Tao-Yuan Taiwan

Funder

National Science Council

Chang Gung Memorial Hospital, Lin-Kou, Taiwan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12944/fullpdf

Reference35 articles.

1. Genetics of hepatocellular carcinoma;Teufel;World J. Gastroenterol.,2007

2. Department of Health (DOH) Vital statistics, taiwan, 2012 2013

3. Recurrence and metastasis of hepatocellular carcinoma: progress and prospects;Zhou;Hepatobiliary Pancreat. Dis. Int.,2002

4. Sorafenib for the treatment of unresectable hepatocellular carcinoma;Kane;Oncologist,2009

5. New agents on the horizon in hepatocellular carcinoma;Zhu;Ther. Adv. Med. Oncol.,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma;Oncology;2018

2. NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization;European Journal of Gastroenterology & Hepatology;2017-06

3. Armored long non-coding RNA MEG3 targeting EGFR based on recombinant MS2 bacteriophage virus-like particles against hepatocellular carcinoma;Oncotarget;2016-03-16